Indices of activity of the nitric oxide system in hemodialysis patients
about
DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strainsTotal nitric oxide production is low in patients with chronic renal diseaseCirculating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal diseaseUremic levels of urea inhibit L-arginine transport in cultured endothelial cellsThe 'intestinal-renal' arginine biosynthetic axis in the aging ratAsymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic reviewThe pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.In vivo renal arginine release is impaired throughout development of chronic kidney diseaseHeadache during haemodialysis in a patient with shunt: a cause for concern?Arginine, arginine analogs and nitric oxide production in chronic kidney disease.Nitric oxide deficiency in chronic kidney disease.Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase.Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis.Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat.Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat.Cellular ADMA: regulation and action.Plasma from ESRD patients inhibits nitric oxide synthase activity in cultured human and bovine endothelial cellsRemoval of asymmetric dimethylarginine during artificial liver support using fractionated plasma separation and adsorption.Uremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function.Increased basal nitric oxide amplifies the association of inflammation with all-cause and cardiovascular mortality in prevalent hemodialysis patients.The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.Relation between exhaled nitric oxide and left ventricular performance in chronic hemodialysis patients.Methylated arginines and nitric oxide in end-stage renal disease: impact of inflammation, oxidative stress and haemodialysis.Rosiglitazone improves aortic arginine transport, through inhibition of PKCalpha, in uremic rats.Plasma Nitrate and Incidence of Cardiovascular Disease and All-Cause Mortality in the Community: The Framingham Offspring Study.Pathophysiological, cardiovascular and neuroendocrine changes in hypertensive patients during the hemodialysis session.L-arginine improves endothelial function, independently of arginine uptake, in aortas from chronic renal failure female rats.The influence of L-arginine on blood pressure, vascular nitric oxide and renal morphometry in the offspring from diabetic mothers.
P2860
Q23909540-D8713593-5E17-4EAE-B75A-D6884D1C9BC4Q28344716-61E4ED3C-8166-4799-A3BB-891551DB90FAQ28361053-9C65604B-68CB-48DE-BC8B-3C95588A96F3Q28365175-0E4E43F6-FB82-46EF-8756-B1B1971BB15BQ28578222-2A996CA9-9C79-45CC-AB7F-103B3BAF82D2Q33646665-DB852603-5887-4840-8D3A-EBA384B36F29Q35055194-BC979F79-CB1D-4C0D-9BA4-E41396299948Q35141332-244E80AF-8AFB-4409-87B3-61E2DCD72563Q35281026-C8975615-75A5-47FD-BD64-E10FBAE509CBQ36577145-2DCB8CFD-2EF2-4091-B610-9879DFA98057Q36967585-53D9ED26-E307-4578-AF39-4DFA8534DE5BQ37324434-C8A6ACA5-BDDA-4AAB-BC57-4663E5C7665CQ37354825-909FB86D-58DD-46AC-8A86-7DC42B80AE48Q37354841-D14EFCD6-B075-4C11-9BFB-7E26BDE4EEEEQ37374585-D22E2D25-3235-4C8A-A290-9F880A69EB6FQ37374622-48EA17B8-5ECB-4326-9282-0CB8C1DDC1CCQ37399711-446366F4-C3E2-4430-B32A-1672466EEBF6Q42134568-2ECDCCAF-BB7D-466B-98D0-44709BE1242FQ43074669-AD51442C-8C2E-45AC-A35E-1D0AB3405A34Q43607645-149EE0BD-53DE-4391-A9FD-C6417CA52D3DQ44725567-606A38CF-C624-43EA-82B2-DDC63F2B0D63Q44797453-B8FC2A5E-D061-4654-81FA-7BD81894D43CQ45132558-90A58413-B490-4B51-A9F3-21741DD13D5EQ46343358-1D022852-466F-4D65-88CF-EB35770936E9Q46558857-5052B004-4820-4CF1-A4E2-222963D0B539Q47094430-60705ACF-52C9-42FE-A870-72E3C461042DQ48477559-99F11F26-C620-49CE-905E-A29AF5BE2755Q51176094-DA40EF76-25C8-4C8A-8CA5-BF20E85FC43EQ51748576-6CD6560B-D26B-4113-91F5-1841E4888D2E
P2860
Indices of activity of the nitric oxide system in hemodialysis patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Indices of activity of the nitric oxide system in hemodialysis patients
@en
Indices of activity of the nitric oxide system in hemodialysis patients.
@nl
type
label
Indices of activity of the nitric oxide system in hemodialysis patients
@en
Indices of activity of the nitric oxide system in hemodialysis patients.
@nl
prefLabel
Indices of activity of the nitric oxide system in hemodialysis patients
@en
Indices of activity of the nitric oxide system in hemodialysis patients.
@nl
P2093
P2860
P1476
Indices of activity of the nitric oxide system in hemodialysis patients
@en
P2093
L S Samsell
M I Sorkin
R J Schmidt
P2860
P304
P356
10.1016/S0272-6386(99)70348-3
P577
1999-08-01T00:00:00Z